Founder and CEO of Credo Science Dr. Ethan Russo (also former Senior Medical Advisor at GW) shares his insights about the acquisition of GW Pharmaceuticals and discusses his experiences in cannabis drug development.  Dr. Deb Kimless also joins the discussion to explore issues around psychedelics patents and the preservation of psychedelics producing fauna which ties into a book Dr. Russo authored 20 years ago about saving the rainforest (link below). Our scientific articles explore innovative cannabis research models and the safety of psychedelics in immunotherapy. At the end of the episode we put on our Good Manufacturing Practice hats, to play one of our favorite games.